300 related articles for article (PubMed ID: 31287426)
1. Precision cytopathology: expanding opportunities for biomarker testing in cytopathology.
Sanchez A; Bocklage T
J Am Soc Cytopathol; 2019; 8(2):95-115. PubMed ID: 31287426
[TBL] [Abstract][Full Text] [Related]
2. Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018.
Pisapia P; Bellevicine C; Malapelle U; De Luca C; Vigliar E; Troncone G
Cancer Cytopathol; 2019 Jun; 127(6):350-357. PubMed ID: 31135103
[TBL] [Abstract][Full Text] [Related]
3. Advances in Molecular Testing Techniques in Cytologic Specimens.
Roy-Chowdhuri S
Surg Pathol Clin; 2018 Sep; 11(3):669-677. PubMed ID: 30190147
[TBL] [Abstract][Full Text] [Related]
4. Precision diagnostics: integration of tissue pathology and genomics in cancer.
Sharma S; George P; Waddell N
Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
[TBL] [Abstract][Full Text] [Related]
5. Molecular predictive testing in precision oncology: The Italian experience.
Vigliar E; Iaccarino A; Sciortino M; De Luca C; Malapelle U; Bellevicine C; Troncone G
Cancer Cytopathol; 2020 Sep; 128(9):622-628. PubMed ID: 32885914
[TBL] [Abstract][Full Text] [Related]
6. Invited review-next-generation sequencing: a modern tool in cytopathology.
Roy-Chowdhuri S; Pisapia P; Salto-Tellez M; Savic S; Nacchio M; de Biase D; Tallini G; Troncone G; Schmitt F
Virchows Arch; 2019 Jul; 475(1):3-11. PubMed ID: 30877381
[TBL] [Abstract][Full Text] [Related]
7. The evolving potential of companion diagnostics.
Khoury JD
Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry practices of cytopathology laboratories: a survey of participants in the College of American Pathologists Nongynecologic Cytopathology Education Program.
Fischer AH; Schwartz MR; Moriarty AT; Wilbur DC; Souers R; Fatheree L; Booth CN; Clayton AC; Kurtyz DF; Padmanabhan V; Crothers BA
Arch Pathol Lab Med; 2014 Sep; 138(9):1167-72. PubMed ID: 24840035
[TBL] [Abstract][Full Text] [Related]
9. Challenges in the clinical implementation of precision medicine companion diagnostics.
Keeling P; Clark J; Finucane S
Expert Rev Mol Diagn; 2020 Jun; 20(6):593-599. PubMed ID: 32336167
[TBL] [Abstract][Full Text] [Related]
10. [Molecular Pathology Diagnosis as Companion Diagnostics].
Fujii S
Gan To Kagaku Ryoho; 2024 Apr; 51(4):383-387. PubMed ID: 38644301
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing in cytology.
Pisapia P; Pepe F; Sgariglia R; Nacchio M; Russo G; Conticelli F; Girolami I; Eccher A; Bellevicine C; Vigliar E; Malapelle U; Troncone G
Cytopathology; 2021 Sep; 32(5):588-595. PubMed ID: 33792981
[TBL] [Abstract][Full Text] [Related]
12. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
13. The application of current classification systems in pediatric cytopathology: Perspectives from the pediatric cytopathology symposium at the 20th International Congress of Cytology 2019.
Monaco SE; Baloch ZW; Rossi ED; Teot LA; Wright C
Cancer Cytopathol; 2019 Oct; 127(10):625-631. PubMed ID: 31553530
[TBL] [Abstract][Full Text] [Related]
14. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Blumenthal GM; Mansfield E; Pazdur R
JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
[No Abstract] [Full Text] [Related]
15. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.
Nagarajan R; Bartley AN; Bridge JA; Jennings LJ; Kamel-Reid S; Kim A; Lazar AJ; Lindeman NI; Moncur J; Rai AJ; Routbort MJ; Vasalos P; Merker JD
Arch Pathol Lab Med; 2017 Dec; 141(12):1679-1685. PubMed ID: 29028368
[TBL] [Abstract][Full Text] [Related]
16. Budget impact and cost-effectiveness: can we afford precision medicine in oncology?
Doble B
Scand J Clin Lab Invest Suppl; 2016; 245():S6-S11. PubMed ID: 27426412
[TBL] [Abstract][Full Text] [Related]
17. Overview of Molecular Testing of Cytology Specimens.
Huang M; Wei S
Acta Cytol; 2020; 64(1-2):136-146. PubMed ID: 30917368
[TBL] [Abstract][Full Text] [Related]
18. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
19. Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist.
Doble B; Tan M; Harris A; Lorgelly P
Expert Rev Mol Diagn; 2015 Feb; 15(2):235-54. PubMed ID: 25142227
[TBL] [Abstract][Full Text] [Related]
20. The world of molecular cytopathology: Predictive testing and precision medicine: Highlights from the eighth International Molecular Cytopathology Meeting in Naples, Italy.
Roy-Chowdhuri S; Rossi ED
Cancer Cytopathol; 2020 Sep; 128(9):599-600. PubMed ID: 32885915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
